Turnstone Biologics Corp. Shareholders' Equity
Turnstone Biologics Corp. had Shareholders' Equity of $14.76 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-08-08
- 2025-06-30: Stockholders' Equity Attributable to Parent $14.76M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $19.99M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $31.47M.
- 2024-09-30: Stockholders' Equity Attributable to Parent $43.64M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-06-30 | $14.76M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $19.99M 10-Q · filed 2025-08-08 |
| 2024-12-31 | $31.47M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $43.64M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $59.74M 10-Q · filed 2025-08-08 |
| 2024-03-31 | $80.01M 10-Q · filed 2025-08-08 |
| 2023-12-31 | $98.67M 10-Q · filed 2025-08-08 |
| 2023-09-30 | $113.90M 10-Q · filed 2024-11-12 |
| 2023-06-30 | -$120.61M 10-Q · filed 2024-11-12 |
| 2023-03-31 | -$100.22M 10-Q · filed 2024-11-12 |
| 2022-12-31 | -$101.47M 10-K · filed 2025-03-31 |
| 2022-09-30 | -$90.05M 10-Q · filed 2023-11-13 |
| 2022-06-30 | -$74.97M 10-Q · filed 2023-11-13 |
| 2022-03-31 | -$93.65M 10-Q · filed 2023-11-13 |
| 2021-12-31 | -$81.85M 10-K · filed 2024-03-22 |